We would like to thank our exhibitors and sponsors for sponsoring this meeting. This includes pharmaceutical companies including AstraZeneca UK and Pfizer Ltd. They have had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the sponsored symposia presentations.
Event Schedule
| Wednesday, February 11, 2026 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9:20 AM - 10:15 AM | Chair’s opening remarks followed by: Eczema management: Assessment, triggers and treatment
Marilyn Eveleigh, Registered Nurse, Midwife, Health Visitor, Editorial Advisor, Nursing in Practice Fay Penart-Buck, Advanced Clinical Practitioner, Boroughbury Medical Centre | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10:25 AM - 11:10 AM | Adopting evidence-based asthma management, case studies and discussion
This is a promotional symposium sponsored and organised by AstraZeneca and is intended for UK HCPs only.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 11:20 AM - 12:05 PM | All you need to know about depression
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 12:15 PM - 1:00 PM | Lifestyle management: Type 2 diabetes and obesity
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 1:10 PM - 1:55 PM | Transforming COPD care: Preventing hospitalisation with primary care interventions
This is a promotional symposium sponsored and organised by AstraZeneca and is intended for UK HCPs only.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2:05 PM - 2:50 PM | High-risk COVID-19 Patients: who are they and how do we find them? This promotional session has been organised and fully funded by Pfizer and is intended for UK Healthcare Professionals only.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3:00 PM - 3:45 PM | Recognising and managing bronchiectasis in practice
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

6 CPD hours
Speakers
Fatima AtharSenior Respiratory Pharmacist, Northern Care Alliance NHS Foundation Trust, Fairfield General Hospital
Beverley BostockAdvanced Nurse Practitioner, Asthma Lead, Chair, Association of Respiratory Nurses, Respiratory Disease Subcommittee
Holly HaywardCommunity Respiratory Nurse Specialist, Midlands Partnership Foundation Trust - Staffordshire






